Philips has issued a recall for Trilogy ventilators be corrected prior to continued use, according to an FDA alert. The alert includes Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal devices.
Philips has issued a recall for Trilogy ventilators be corrected prior to continued use, according to an FDA alert. The alert includes Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal devices.
Read More
Devices like the Philips InCourage system help patients with COPD and cystic fibrosis manage mucus and reduce the risk of infections.
Read More
Philips Dreamwear System’s new fitting technology and a modular mask frame aim to improve patient comfort and clinical efficiency in sleep therapy.
Read More
Philips Respironics is recalling certain DreamStation Auto CPAP and Auto BiPAP devices, according to a September 12th FDA alert.
Read More
Masimo and Royal Philips have agreed to a multi-year renewal and expansion of their strategic partnership focused on patient monitoring technologies.
Read More
Philips Respironics has issued updated instructions for its V30, A30, and A40 BiPAP devices due to a failure in the ventilator inoperative alarm, which can cause interruption or loss of therapy, according to an FDA alert.
Read More
The partnership will integrate Medtronic’s technologies—like Nellcor, Microstream, and BIS—into Philips monitoring systems, bundled with essential supplies to simplify procurement and reduce system complexity.
Read More
A closer look at suction and secretion clearance devices from ABM Respiratory, Baxter, Neotech, Philips, Precision Medical, Sentec, Seoil Pacific, and Tactile Medical.
Read More
RT takes a look at positive airway pressure interfaces, masks, and sleep therapy devices from Cadwell, Mercury Medical, and Philips.
Read More
Royal Philips has signed an agreement to sell its Emergency Care business — which includes AEDs, advanced life support defibrillators, and prehospital monitoring solutions — to Bridgefield Capital.
Read More
Some patients who have been impacted by Lincare and Philips Respironics have joined forces with these corporations to lobby for an end to Medicare’s competitive bidding process for oxygen and to make liquid oxygen available.
Read More
A report from ProPublica says that Lincare was supposed to supply the most ailing patients with new CPAPs but instead diverted the devices to new customers who would deliver greater profits for the company.
Read More
Philips has issued updated use instructions for several ventilator models following an FDA Class I recall due to risks of aerosol deposits accumulating on internal flow sensors when in-line nebulizers are used.
Read More
The correction addresses potential risks of aerosol buildup on ventilator flow sensors when using in-line nebulizers.
Read More
Philips Respironics has issued a software update and revised user instructions for its Trilogy ventilators to address previously reported and new safety risks.
Read More
Philips Respironics has issued a recall for its OmniLab Advanced+ ventilators due to an alarm failure that can lead to therapy interruption or loss of ventilation.
Read More
Philips Respironics updated the use instructions for BiPAP V30, A30, and A40 ventilators due to potential therapy interruptions and serious health risks.
Read More
Philips Respironics Inc is recalling its Trilogy Evo continuous ventilators due to a possible software-related power malfunction.
Read More
The company anticipates the settlement will resolve all personal injury and medical monitoring claims related to its June 2021 recall.
Read More
The decree mandates a recall remediation plan and production restrictions to address safety concerns following the widespread 2021 recall of CPAP and BiPAP machines.
Read More
The FDA issued an update on the June 2021 recall of Philips Respironics ventilators, BiPAP and CPAP devices for the period of July 1, 2023 through September 30, 2023.
Read More
Gerald E. McGinnis, founder of Respironics and creator of the first CPAP machine to treat sleep apnea, died on Jan 25 at age 89.
Read More
Until the requirements of the consent decree are met, Philips Respironics will not sell new CPAP, BiPAP, or other respiratory care devices in the US.
Read More
Philips Respironics will end the sale of “hospital ventilation products, certain home ventilation products, portable and stationary oxygen concentrators and sleep diagnostic products,” according to a company announcement.
Read More
